Volume Alert - PHM 21.09 Pultegroup $PHM Hit a high today

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - PHM 21.09 Pultegroup $PHM Hit a high today of 21.49 Closing the day 10:30 at 21.09 -0.21 -0.99% With a day low of 21.08 and a total volume of 2,463,269.

PHM Recent Posts: http://investorshangout.com/PulteGroup-Inc-PHM-52290/

PHM Pultegroup Recent Headline News

Pulte Homes Shares Up 12.1% Since SmarTrend's Buy Recommendation (PHM)
Comtex SmarTrend(R) - 1 hr 37 mins ago
SmarTrend identified an Uptrend for Pulte Homes (NYSE HM) on October 21st, 2014 at $19.00. In approximately 4 weeks, Pulte Homes has returned 12.08% as of today's recent price of $21.29.
PHM: 21.04 (-0.26)

Homebuilding Is Picking Up Again, but It's All About Rentals
at The Street - 1 hr 38 mins ago
Housing construction is finally showing signs of recovery, but not because more Americans are buying homes.
LEN: 45.64 (-0.05), RYL: 37.60 (-0.18), PHM: 21.04 (-0.26), KBH: 17.05 (-0.02), TOL: 33.98 (+0.09)

Homebuilders Are Feeling Lucky For Good Reason
Markos Kaminis - at Seeking Alpha - Wed Nov 19, 2:54AM CST

DHI: 24.71 (+0.08), LEN: 45.64 (-0.05), XHB: 32.37 (+0.12), PHM: 21.04 (-0.26), BAC: 17.03 (-0.11), BZH: 19.48 (-0.22), KBH: 17.05 (-0.02), TOL: 33.98 (+0.09)

Pulte Homes Rises 1.57% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Nov 18, 5:10PM CST
Pulte Homes (NYSE HM) traded in a range yesterday that spanned from a low of $20.93 to a high of $21.33. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $21.07 on volume of 6.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PHM: 21.04 (-0.26)

Pulte Homes (PHM) Approaches New Upside Target of $21.30
Comtex SmarTrend(R) - Tue Nov 18, 1:00PM CST
Pulte Homes (NYSE HM) has opened bullishly above the pivot of $20.91 today and has reached the first level of resistance at $21.13. Should the shares continue to rise, the resistance pivots of $21.30 and $21.69 will be of interest.
PHM: 21.04 (-0.26)

5 Worst Big Cities For Buying A Home, And 5 Good Ones
at Investor's Business Daily - Sat Nov 15, 7:02AM CST
Homeownership is unaffordable in some of the biggest and most popular U.S. cities. So says the new edition of an annual study that looks at how the cost of buying a home stacks up against income and expenses in various metro areas. The study by...
DHI: 24.71 (+0.08), LEN: 45.64 (-0.05), RATE: 11.81 (-0.14), PHM: 21.04 (-0.26), KBH: 17.05 (-0.02)

Lennar Rising: Land Stake, Sales, Margins Give Lift
at Investor's Business Daily - Thu Nov 13, 4:18PM CST
As the nation's housing recovery inched forward, homebuilder Lennar raced ahead. It bought land on the cheap around the U.S., grabbed market share from smaller, less-capitalized builders and is now posting peer-leading margins. Gross margin on home...
DHI: 24.71 (+0.08), LEN: 45.64 (-0.05), PHM: 21.04 (-0.26)

Stock Market News for November 12, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 9:10AM CST
Benchmarks were little changed on Tuesday as investors hardly found any reason to place big bets
DHI: 24.71 (+0.08), MON: 119.35 (+0.02), NEM: 19.42 (-0.48), BZH: 19.48 (-0.22), CVC: 18.91 (-0.22), JNPR: 21.38 (-0.20), ZTS: 43.69 (-0.50), LEN: 45.64 (-0.05), LYB: 88.89 (-0.15), CF: 273.44 (+3.75), PHM: 21.04 (-0.26), DD: 70.93 (-0.23), TWC: 142.16 (-0.43), TOL: 33.98 (+0.09), DOW: 51.70 (-0.37), ECL: 112.86 (-0.32)

'Fast Money' Recap: Will Housing Stocks Rally Into Year's End?
at The Street - Wed Nov 12, 4:00AM CST
The trading panel says the housing market will be helped along by lower interest rates and an improving labor market, while Alibaba is still a buy after Single's Day.
CATO: 36.62 (+0.12), AMZN: 326.54 (+1.61), HD: 97.10 (+1.12), FXA: 86.34 (-0.97), BBY: 36.12 (+1.22), BZH: 19.48 (-0.22), FINL: 27.22 (+0.08), YHOO: 50.61 (-1.14), PLCE: 50.64 (-0.03), QCOM: 70.76 (-1.25), PHM: 21.04 (-0.26), FXC: 87.67 (-0.32), LOW: 62.33 (+3.80), KBH: 17.05 (-0.02), YNDX: 25.92 (+0.06), BABA: 109.34 (-1.47)

20 Veterans And Their Families Get The Gift Of Homeownership In 2014
PR Newswire - Tue Nov 11, 11:30AM CST
Veterans and their families across the country are realizing the dream of homeownership today as PulteGroup's Built to Honor program is pleased to announce it has reached its goal of building a new home for 20 veterans and their families.
PHM: 21.04 (-0.26)

Watch for Pulte Homes to Potentially Pullback After Gaining 1.75% Yesterday
Comtex SmarTrend(R) - Mon Nov 10, 4:21PM CST
Pulte Homes (NYSE HM) traded in a range yesterday that spanned from a low of $20.25 to a high of $20.67. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $19.97 on volume of 8.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PHM: 21.04 (-0.26)

Pulte Homes Set to Possibly Pullback After Yesterday's Rally of 1.75%
Comtex SmarTrend(R) - Mon Nov 10, 4:20PM CST
Pulte Homes (NYSE HM) traded in a range yesterday that spanned from a low of $20.25 to a high of $20.67. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $19.97 on volume of 8.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PHM: 21.04 (-0.26)

Toll Bros. Q4 Sales Up Amid Gains In The West
at Investor's Business Daily - Mon Nov 10, 12:04PM CST
Toll Bros. (TOL) pre-announced a 29.3% fourth-quarter revenue rise as the average price of homes delivered rose 6.3% year over year to $747,000 and homebuilding revenue grew especially in the Western region. By early afternoon, shares of the company,...
DHI: 24.71 (+0.08), LEN: 45.64 (-0.05), PHM: 21.04 (-0.26), TOL: 33.98 (+0.09)

Pulte Homes Earnings In Retrospect: Up 2.3% in the Last 18 Days (PHM)
Comtex SmarTrend(R) - Mon Nov 10, 9:20AM CST
18 days ago, on October 23rd, 2014, Pulte Homes (NYSE HM) reported its earnings. Analysts, on average, expected earnings of $0.36 per share on sales of $1.6 billion. The company actually reported EPS of $0.37 on sales of $1.6 billion, beating EPS estimates by $0.01 and beating revenue estimates by $11.6 million. Since the company's report, shares of Pulte Homes have risen from $19.51 to $19.96, representing a gain of 2.3% in the past 18 days.
PHM: 21.04 (-0.26)

Homebuilders higher after early Toll Bros. results
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 9:08AM CST

DHI: 24.71 (+0.08), LEN: 45.64 (-0.05), RYL: 37.60 (-0.18), XHB: 32.37 (+0.12), ITB: 25.18 (+0.02), PHM: 21.04 (-0.26), KBH: 17.05 (-0.02), HOV: 4.14 (+0.03)

PulteGroup's Presentation At The UBS Building & Building Products Annual CEO Conference To Be Webcast Live
PR Newswire - Fri Nov 07, 11:05AM CST
PulteGroup, Inc. (NYSE: PHM), will present at the UBS Building & Building Products Annual CEO Conference on Thursday, November 13, 2014, at 3:15 p.m. (ET).
PHM: 21.04 (-0.26)

Housing Update Market: It's Getting Worse
Dave Kranzler - at Seeking Alpha - Thu Nov 06, 5:29AM CST

DHI: 24.71 (+0.08), LEN: 45.64 (-0.05), RYL: 37.60 (-0.18), PHM: 21.04 (-0.26), BZH: 19.48 (-0.22), KBH: 17.05 (-0.02), TOL: 33.98 (+0.09)

PulteGroup, Inc.: Analysis Of Q3 Earnings
CapitalCube - at Seeking Alpha - Sun Nov 02, 6:38AM CST
By Chaith Kondragunta The table below shows the preliminary results and recent trends for key metrics such as revenues and net income (See complete table at the end of this report): 2013-09-30 2013-12-31 2014-03-31 2014-06-30 ...
PHM: 21.04 (-0.26)

PulteGroup Inc. (PHM) Stock Research Links

PHM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 72

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 105

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 337

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 508

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 83

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 727

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 248

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 587

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 171

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 341

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading

Top 5 Most Recently Viewed Articles

Introducing the Innovative Garage Door Opener for Homes

Updated Category News Views 201

Introducing the G3120HL Garage Door Opener Modern Design with Advanced Features – Beyond Basic. Built for More. MT. HOPE, Ohio — Genie®, known for its exceptional garage door innovations, has launched the G3120HL opener, fusing cutting-edge technology with an impressive industrial design. This opener enhances security, convenience, and durability, perfectly suited...

Continue Reading
Costamare Inc. Announces Latest Dividends for Investors

Updated Category News Views 68

Costamare Inc. (NYSE: CMRE) dropped a bombshell back in 2024, announcing hefty cash dividends that had traders buzzing. They laid out payments of US $0.476563 per share for the 7.625% Series B Cumulative Redeemable Perpetual Preferred Stock, US $0.531250 for the 8.50% Series C, and US $0.546875 per share for the 8.75% Series D Preferred Stock. For investors eyeing a...

Continue Reading
TranscribeGlass Expands Orders for Vuzix Smart Glasses

Updated Category News Views 159

TranscribeGlass Orders More Vuzix Z100 Smart Glasses AI-driven speech-to-text technology is revolutionizing how we communicate. For those who are deaf or hard of hearing, this technology enhances accessibility and allows for real-time closed captions in various environments. Continued Demand for Transcription Solutions The demand for effective communication solutions is...

Continue Reading
Sandoz Q1 2025 Financial Performance Highlights and Insights

Updated Category News Views 544

Sandoz Reports Robust Q1 2025 Financials Sandoz has shared its financial updates for the first quarter of 2025, reflecting a strong performance that aligns well with the company's expectations. This report is particularly notable as it confirms the company's ongoing commitment to delivering high-quality generic and biosimilar medicines to global markets. Q1 Sales...

Continue Reading
Zero Candida Technologies Expands Investor Access and DTC Eligibility

Updated Category News Views 124

Exciting Developments from Zero Candida Technologies Zero Candida Technologies, Inc. (ZCT) is making significant strides in revolutionizing women's health with their innovative medical device approach. This FemTech company has recently announced that its common shares are now eligible for Depository Trust Company (DTC) electronic clearing and settlement services. This...

Continue Reading